Vitamin K: Infection, Inflammation, and Auto-Immunity

References

• Wong F, de la Fuente-Nunez C, Collins JJ. Leveraging artificial intelligence in the fight against infectious diseases. Science. 2023;381(6654):164–170. doi:10.1126/science.adh1114
   PubMed Web of Science ®Google Scholar
• Sangeetha Vijayan P, Xavier J, Valappil MP. A review of immune modulators and immunotherapy in infectious diseases. Mol Cell Biochem. 2023. doi:10.1007/s11010-023-04825-w
   PubMed Web of Science ®Google Scholar
• Zheng Y, Liu Q, Goronzy JJ, Weyand CM. Immune aging - A mechanism in autoimmune disease. Semin Immunol. 2023;69:101814. doi:10.1016/j.smim.2023.101814
   PubMed Web of Science ®Google Scholar
• Merra G, Dominici F, Gualtieri P, et al. Role of vitamin K2 in bone-vascular crosstalk. Int J Vitam Nutr Res. 2022. doi:10.1024/0300-9831/a000761
   PubMed Web of Science ®Google Scholar
• Swanson JC, Suttie JW. Vitamin K dependent in vitro production of prothrombin. Biochemistry. 1982;21(23):6011–6018. doi:10.1021/bi00266a044
   PubMed Web of Science ®Google Scholar
• Schurgers LJ, Vermeer C. Determination of phylloquinone and menaquinones in food. Effect of food matrix on circulating vitamin K concentrations. Haemostasis. 2000;30(6):298–307. doi:10.1159/000054147
   PubMedGoogle Scholar
• Dunlop E, Jakobsen J, Jensen MB, et al. Vitamin K content of cheese, yoghurt and meat products in Australia. Food Chem. 2022;397:133772. doi:10.1016/j.foodchem.2022.133772
   PubMed Web of Science ®Google Scholar
• Kamao M, Suhara Y, Tsugawa N, et al. Vitamin K content of foods and dietary vitamin K intake in Japanese young women. J Nutr Sci Vitaminol. 2007;53(6):464–470. doi:10.3177/jnsv.53.464
   PubMed Web of Science ®Google Scholar
• Stafford DW. The vitamin K cycle. J Thromb Haemost. 2005;3(8):1873–1878. doi:10.1111/j.1538-7836.2005.01419.x
   PubMed Web of Science ®Google Scholar
• Bentley R, Meganathan R. Biosynthesis of vitamin K (menaquinone) in bacteria. Microbiol Rev. 1982;46(3):241–280. doi:10.1128/mr.46.3.241-280.1982
   PubMedGoogle Scholar
• Beulens JWJ, Booth SL, van den Heuvel EG, Stoecklin E, Baka A, Vermeer C. The role of menaquinones (vitamin K₂) in human health. Br J Nutr. 2013;110(8):1357–1368. doi:10.1017/S0007114513001013
   PubMed Web of Science ®Google Scholar
• Shearer MJ, Okano T. Key pathways and regulators of vitamin K function and intermediary metabolism. Annu Rev Nutr. 2018;38:127–151. doi:10.1146/annurev-nutr-082117-051741
   PubMed Web of Science ®Google Scholar
• Saglani S, Yates L, Lloyd CM. Immunoregulation of asthma by type 2 cytokine therapies: treatments for all ages? Eur J Immunol. 2023;53(8):e2249919. doi:10.1002/eji.202249919
   PubMedGoogle Scholar
• Kimur I, Tanizaki Y, Sato S, Saito K, Takahashi K. Menaquinone (vitamin K2) therapy for bronchial asthma. II. Clinical effect of menaquinone on bronchial asthma. Acta Med Okayama. 1975;29(2):127–135.
   PubMed Web of Science ®Google Scholar
• Janssen R, Vermeer C. Vitamin K deficit and elastolysis theory in pulmonary elasto-degenerative diseases. Med Hypotheses. 2017;108:38–41. doi:10.1016/j.mehy.2017.07.029
   PubMed Web of Science ®Google Scholar
• Jespersen T, Kampmann FB, Dantoft TM, et al. The association of vitamin K status with lung function and disease in a general population. ERJ Open Res. 2023;9:5.
   Google Scholar
• Aziz M, Fatima R, Assaly R. Elevated interleukin-6 and severe COVID-19: a meta-analysis. J Med Virol. 2020;92(11):2283–2285. doi:10.1002/jmv.25948
   PubMed Web of Science ®Google Scholar
• McElvaney OJ, Curley GF, Rose-John S, McElvaney NG. Interleukin-6: obstacles to targeting a complex cytokine in critical illness. Lancet Respir Med. 2021;9(6):643–654. doi:10.1016/S2213-2600(21)00103-X
   PubMed Web of Science ®Google Scholar
• Liu B, Li M, Zhou Z, Guan X, Xiang Y. Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)? J Autoimmun. 2020;111:102452. doi:10.1016/j.jaut.2020.102452
   PubMed Web of Science ®Google Scholar
• Visser MPJ, Dofferhoff ASM, van den Ouweland JMW, et al. Effects of Vitamin D and K on Interleukin-6 in COVID-19. Front Nutr. 2021;8:761191. doi:10.3389/fnut.2021.761191
   PubMed Web of Science ®Google Scholar
• Mangge H, Prueller F, Dawczynski C, et al. Dramatic decrease of vitamin K2 subtype menaquinone-7 in COVID-19 patients. Antioxidants. 2022;11:7.
   Web of Science ®Google Scholar
• Su J, Luo Y, Hu S, Tang L, Ouyang S. Advances in research on type 2 diabetes mellitus targets and therapeutic agents. Int J Mol Sci. 2023;24:17. doi:10.3390/ijms241713381
   Web of Science ®Google Scholar
• Sakamoto N, Nishiike T, Iguchi H, Sakamoto K. Relationship between acute insulin response and vitamin K intake in healthy young male volunteers. Diabetes Nutr Metab. 1999;12(1):37–41.
   PubMedGoogle Scholar
• Sakamoto N, Nishiike T, Iguchi H, Sakamoto K. Possible effects of one week vitamin K (menaquinone-4) tablets intake on glucose tolerance in healthy young male volunteers with different descarboxy prothrombin levels. Clin Nutr. 2000;19(4):259–263. doi:10.1054/clnu.2000.0102
   PubMed Web of Science ®Google Scholar
• Yoshida M, Booth SL, Meigs JB, Saltzman E, Jacques PF. Phylloquinone intake, insulin sensitivity, and glycemic status in men and women12. Am J Clin Nutr. 2008;88(1):210–215. doi:10.1093/ajcn/88.1.210
   PubMed Web of Science ®Google Scholar
• Yoshida M, Jacques PF, Meigs JB, et al. Effect of vitamin K supplementation on insulin resistance in older men and women. Diabetes Care. 2008;31(11):2092–2096. doi:10.2337/dc08-1204
   PubMed Web of Science ®Google Scholar
• Rasekhi H, Karandish M, Jalali MT, et al. Phylloquinone supplementation improves glycemic status independent of the effects of adiponectin levels in premonopause women with prediabetes: a double-blind randomized controlled clinical trial. J Diabetes Metab Disord. 2015;14(1):1. doi:10.1186/s40200-014-0127-9
   PubMedGoogle Scholar
• Rasekhi H, Karandish M, Jalali MT, et al. The effect of vitamin K1 supplementation on sensitivity and insulin resistance via osteocalcin in prediabetic women: a double-blind randomized controlled clinical trial. Eur J Clin Nutr. 2015;69(8):891–895. doi:10.1038/ejcn.2015.17
   PubMed Web of Science ®Google Scholar
• Zhang Q, Yan Y. The role of natural flavonoids on neuroinflammation as a therapeutic target for Alzheimer’s disease: a narrative review. Neural Regen Res. 2023;18(12):2582–2591. doi:10.4103/1673-5374.373680
   PubMed Web of Science ®Google Scholar
• Alisi L, Cao R, De Angelis C, et al. The relationships between vitamin K and cognition: a review of current evidence. Front Neurol. 2019;10:239. doi:10.3389/fneur.2019.00239
   PubMed Web of Science ®Google Scholar
• Wattenberg BW. Intra- and intercellular trafficking in sphingolipid metabolism in myelination. advances in Biological Regulation. 2019;71:97–103. doi:10.1016/j.jbior.2018.11.002
   PubMedGoogle Scholar
• Manfioletti G, Brancolini C, Avanzi GC, Schneider C. The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol Cell Biol. 1993;13:4976–4985. doi:10.1128/mcb.13.8.4976-4985.1993
   PubMed Web of Science ®Google Scholar
• Bellido-Martín L, de Frutos PG. Vitamin K-dependent actions of Gas6. Vitam Horm. 2008;78:185–209.
   PubMed Web of Science ®Google Scholar
• Funakoshi H, Yonemasu T, Nakano T, Matumoto K, Nakamura T. Identification of Gas6, a putative ligand for Sky and Axl receptor tyrosine kinases, as a novel neurotrophic factor for hippocampal neurons. J Neurosci Res. 2002;68(2):150–160. doi:10.1002/jnr.10211
   PubMed Web of Science ®Google Scholar
• Yagami T, Ueda K, Asakura K, et al. Gas6 rescues cortical neurons from amyloid beta protein-induced apoptosis. Neuropharmacology. 2002;43(8):1289–1296. doi:10.1016/S0028-3908(02)00333-7
   PubMed Web of Science ®Google Scholar
• Liu D, Guo H, Griffin JH, Fernández JA, Zlokovic BV. Protein S confers neuronal protection during ischemic/hypoxic injury in mice. Circulation. 2003;107(13):1791–1796. doi:10.1161/01.CIR.0000058460.34453.5A
   PubMed Web of Science ®Google Scholar
• Pluta R, Januszewski S, Czuczwar SJ. Brain ischemia as a prelude to alzheimer’s disease. Front Aging Neurosci. 2021;13:636653. doi:10.3389/fnagi.2021.636653
   PubMed Web of Science ®Google Scholar
• Dexter DT, Jenner P. Parkinson disease: from pathology to molecular disease mechanisms. Free Radic Biol Med. 2013;62:132–144. doi:10.1016/j.freeradbiomed.2013.01.018
   PubMed Web of Science ®Google Scholar
• Lopez-Fabuel I, Martin-Martin L, Resch-Beusher M, Azkona G, Sanchez-Pernaute R, Bolaños JP. Mitochondrial respiratory chain disorganization in Parkinson’s disease-relevant PINK1 and DJ1 mutants. Neurochem Int. 2017;109:101–105. doi:10.1016/j.neuint.2017.03.023
   PubMed Web of Science ®Google Scholar
• Vos M, Esposito G, Edirisinghe JN, et al. Vitamin K2 is a mitochondrial electron carrier that rescues pink1 deficiency. Science. 2012;336(6086):1306–1310. doi:10.1126/science.1218632
   PubMed Web of Science ®Google Scholar
• Prasuhn J, Kasten M, Vos M, et al. The use of vitamin K2 in patients with parkinson’s disease and mitochondrial dysfunction (PD-K2): a theranostic pilot study in a placebo-controlled parallel group design. Front Neurol. 2020;11:592104. doi:10.3389/fneur.2020.592104
   PubMed Web of Science ®Google Scholar
• Yu Y-X, Yu X-D, Cheng Q-Z, Tang L, Shen M-Q. The association of serum vitamin K2 levels with Parkinson’s disease: from basic case-control study to big data mining analysis. Aging. 2020;12(16):16410–16419. doi:10.18632/aging.103691
   PubMedGoogle Scholar
• da Silva FL, Coelho Cerqueira E, de Freitas MS, Gonçalves DL, Costa LT, Follmer C. Vitamins K interact with N-terminus α-synuclein and modulate the protein fibrillization in vitro. Exploring the interaction between quinones and α-synuclein. Neurochem Int. 2013;62(1):103–112. doi:10.1016/j.neuint.2012.10.001
   PubMed Web of Science ®Google Scholar
• Zafar E, Maqbool MF, Iqbal A, et al. A comprehensive review on anticancer mechanism of bazedoxifene. Biotechnol Appl Biochem. 2022;69(2):767–782. doi:10.1002/bab.2150
   PubMed Web of Science ®Google Scholar
• Fernald K, Kurokawa M. Evading apoptosis in cancer. Trends Cell Biol. 2013;23(12):620–633. doi:10.1016/j.tcb.2013.07.006
   PubMed Web of Science ®Google Scholar
• Bouzahzah B, Nishikawa Y, Simon D, Carr BI. Growth control and gene expression in a new hepatocellular carcinoma cell line, Hep40: inhibitory actions of vitamin K. J Cell Physiol. 1995;165(3):459–467. doi:10.1002/jcp.1041650303
   PubMed Web of Science ®Google Scholar
• Chlebowski RT, Dietrich M, Akman S, Block JB. Vitamin K3 inhibition of malignant murine cell growth and human tumor colony formation. Cancer Treat Rep. 1985;69(5):527–532.
   PubMedGoogle Scholar
• Wu FY, Liao WC, Chang HM. Comparison of antitumor activity of vitamins K1, K2 and K3 on human tumor cells by two (MTT and SRB) cell viability assays. Life Sci. 1993;52(22):1797–1804. doi:10.1016/0024-3205(93)90469-J
   PubMed Web of Science ®Google Scholar
• Hitomi M, Yokoyama F, Kita Y, et al. Antitumor effects of vitamins K1, K2 and K3 on hepatocellular carcinoma in vitro and in vivo. Int J Oncol. 2005;26(3):713–720.
   PubMed Web of Science ®Google Scholar
• Ozaki I, Zhang H, Mizuta T, et al. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation. Clin Cancer Res. 2007;13(7):2236–2245. doi:10.1158/1078-0432.CCR-06-2308
   PubMed Web of Science ®Google Scholar
• Xia J, Matsuhashi S, Hamajima H, et al. The role of PKC isoforms in the inhibition of NF-κB activation by vitamin K2 in human hepatocellular carcinoma cells. J Nutr Biochem. 2012;23(12):1668–1675. doi:10.1016/j.jnutbio.2011.11.010
   PubMed Web of Science ®Google Scholar
• Maniwa Y, Kasukabe T, Kumakura S. Vitamin K2 and cotylenin A synergistically induce monocytic differentiation and growth arrest along with the suppression of c-MYC expression and induction of cyclin G2 expression in human leukemia HL-60 cells. Int J Oncol. 2015;47(2):473–480. doi:10.3892/ijo.2015.3028
   PubMed Web of Science ®Google Scholar
• Otsuka M, Kato N, Shao RX, et al. Vitamin K2 inhibits the growth and invasiveness of hepatocellular carcinoma cells via protein kinase A activation. Hepatology. 2004;40(1):243–251. doi:10.1002/hep.20260
   PubMed Web of Science ®Google Scholar
• Liu W, Nakamura H, Yamamoto T, et al. Vitamin K2 inhibits the proliferation of HepG2 cells by up-regulating the transcription of p21 gene. Hepatol Res. 2007;37(5):360–365. doi:10.1111/j.1872-034X.2007.00058.x
   PubMed Web of Science ®Google Scholar
• Maurya PK, Kumar P, Chandra P. Biomarkers of oxidative stress in erythrocytes as a function of human age. World J Methodol. 2015;5(4):216–222. doi:10.5662/wjm.v5.i4.216
   PubMedGoogle Scholar
• Harshman SG, Shea MK. The role of vitamin K in chronic aging diseases: inflammation, cardiovascular disease, and osteoarthritis. Curr Nutr Rep. 2016;5(2):90–98. doi:10.1007/s13668-016-0162-x
   PubMedGoogle Scholar
• Popa DS, Bigman G, Rusu ME. The role of vitamin K in humans: implication in aging and age-associated diseases. Antioxidants. 2021;10:4.
   Web of Science ®Google Scholar
• Tsugawa N, Shiraki M. Vitamin K nutrition and bone health. Nutrients. 2020;12(7). doi:10.3390/nu12071909
   Web of Science ®Google Scholar
• Shea MK, Kritchevsky SB, Hsu FC, et al. The association between vitamin K status and knee osteoarthritis features in older adults: the health, aging and body composition study. Osteoarthritis Cartilage. 2015;23(3):370–378. doi:10.1016/j.joca.2014.12.008
   PubMed Web of Science ®Google Scholar
• Binkley NC, Krueger DC, Kawahara TN, Engelke JA, Chappell RJ, Suttie JW. A high phylloquinone intake is required to achieve maximal osteocalcin gamma-carboxylation. Am J Clin Nutr. 2002;76(5):1055–1060. doi:10.1093/ajcn/76.5.1055
   PubMed Web of Science ®Google Scholar
• Lin X, Brennan-Speranza TC, Levinger I, Yeap BB. Undercarboxylated osteocalcin: experimental and human evidence for a role in glucose homeostasis and muscle regulation of insulin sensitivity. Nutrients. 2018;10(7):847. doi:10.3390/nu10070847
   PubMed Web of Science ®Google Scholar
• Luukinen H, Käkönen SM, Pettersson K, et al. Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin. J Bone Miner Res. 2000;15(12):2473–2478. doi:10.1359/jbmr.2000.15.12.2473
   PubMed Web of Science ®Google Scholar
• Sim M, Lewis JR, Prince RL, et al. The effects of vitamin K-rich green leafy vegetables on bone metabolism: a 4-week randomised controlled trial in middle-aged and older individuals. Bone Rep. 2020;12:100274. doi:10.1016/j.bonr.2020.100274
   PubMedGoogle Scholar
• Bultynck C, Munim N, Harrington DJ, et al. Prevalence of vitamin K deficiency in older people with Hip fracture. Acta Clin Belg. 2020;75(2):136–140. doi:10.1080/17843286.2018.1564174
   PubMed Web of Science ®Google Scholar
• Moore AE, Kim E, Dulnoan D, et al. Serum vitamin K(1) (phylloquinone) is associated with fracture risk and Hip strength in post-menopausal osteoporosis: a cross-sectional study. Bone. 2020;141:115630. doi:10.1016/j.bone.2020.115630
   PubMed Web of Science ®Google Scholar
• Hooshmand S, Kern M, Metti D, et al. The effect of two doses of dried plum on bone density and bone biomarkers in osteopenic postmenopausal women: a randomized, controlled trial. Osteoporos Int. 2016;27(7):2271–2279. doi:10.1007/s00198-016-3524-8
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Weitzmann MN. Vitamin K2 stimulates osteoblastogenesis and suppresses osteoclastogenesis by suppressing NF-κB activation. Int J Mol Med. 2011;27(1):3–14. doi:10.3892/ijmm.2010.562
   PubMed Web of Science ®Google Scholar
• Capozzi A, Scambia G, Lello S. Calcium, vitamin D, vitamin K2, and magnesium supplementation and skeletal health. Maturitas. 2020;140:55–63. doi:10.1016/j.maturitas.2020.05.020
   PubMed Web of Science ®Google Scholar
• Dai L, Schurgers LJ, Shiels PG, Stenvinkel P. Early vascular ageing in chronic kidney disease: impact of inflammation, vitamin K, senescence and genomic damage. Nephrol Dial Transplant. 2020;35(Suppl 2):ii31–ii7. doi:10.1093/ndt/gfaa006
   PubMedGoogle Scholar
• Mozos I, Stoian D, Luca CT. Crosstalk between vitamins A, B12, D, K, C, and E status and arterial stiffness. Dis Markers. 2017;2017:8784971. doi:10.1155/2017/8784971
   PubMed Web of Science ®Google Scholar
• Roumeliotis S, Dounousi E, Salmas M, Eleftheriadis T, Liakopoulos V. vascular calcification in chronic kidney disease: the role of vitamin K- dependent matrix gla protein. Front Med Lausanne. 2020;7:154. doi:10.3389/fmed.2020.00154
   PubMed Web of Science ®Google Scholar
• Ueland T, Dahl CP, Gullestad L, et al. Circulating levels of non-phosphorylated undercarboxylated matrix Gla protein are associated with disease severity in patients with chronic heart failure. Clin Sci (Lond). 2011;121(3):119–127. doi:10.1042/CS20100589
   PubMed Web of Science ®Google Scholar
• Puzantian H, Akers SR, Oldland G, et al. Circulating dephospho-uncarboxylated matrix gla-protein is associated with kidney dysfunction and arterial stiffness. Am J Hypertens. 2018;31(9):988–994. doi:10.1093/ajh/hpy079
   PubMed Web of Science ®Google Scholar
• Caluwé R, Vandecasteele S, Van Vlem B, Vermeer C, De Vriese AS. Vitamin K2 supplementation in haemodialysis patients: a randomized dose-finding study. Nephrol Dial Transplant. 2014;29(7):1385–1390. doi:10.1093/ndt/gft464
   PubMed Web of Science ®Google Scholar
• Shioi A, Morioka T, Shoji T, Emoto M. The inhibitory roles of vitamin K in progression of vascular calcification. Nutrients. 2020;12(2). doi:10.3390/nu12020583
   PubMed Web of Science ®Google Scholar
• Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology. 2014;146(6):1489–1499. doi:10.1053/j.gastro.2014.02.009
   PubMed Web of Science ®Google Scholar
• Nadeem MS, Kumar V, Al-Abbasi FA, Kamal MA, Anwar F. Risk of colorectal cancer in inflammatory bowel diseases. Semin Cancer Biol. 2020;64:51–60. doi:10.1016/j.semcancer.2019.05.001
   PubMed Web of Science ®Google Scholar
• Yoon SM. Micronutrient deficiencies in inflammatory bowel disease: trivial or crucial? Intest Res. 2016;14(2):109–110. doi:10.5217/ir.2016.14.2.109
   PubMedGoogle Scholar
• Lai Y, Masatoshi H, Ma Y, Guo Y, Zhang B. Role of vitamin K in intestinal health. Front Immunol. 2021;12:791565. doi:10.3389/fimmu.2021.791565
   PubMed Web of Science ®Google Scholar
• Varsha MK, Thiagarajan R, Manikandan R, Dhanasekaran G. Vitamin K1 alleviates streptozotocin-induced type 1 diabetes by mitigating free radical stress, as well as inhibiting NF-κB activation and iNOS expression in rat pancreas. Nutrition. 2015;31(1):214–222. doi:10.1016/j.nut.2014.05.012
   PubMed Web of Science ®Google Scholar
• Iwamoto J, Seki A, Sato Y, Matsumoto H, Takeda T, Yeh JK. Vitamin K₂ prevents hyperglycemia and cancellous osteopenia in rats with streptozotocin-induced type 1 diabetes. Calcif Tissue Int. 2011;88(2):162–168. doi:10.1007/s00223-010-9441-5
   PubMed Web of Science ®Google Scholar
• Dulamea AO. Role of oligodendrocyte dysfunction in demyelination, remyelination and neurodegeneration in multiple sclerosis. Adv Exp Med Biol. 2017;958:91–127. doi:10.1007/978-3-319-47861-6_7
   PubMed Web of Science ®Google Scholar
• Lasemi R, Kundi M, Moghadam NB, Moshammer H, Hainfellner JA. Vitamin K2 in multiple sclerosis patients. Wien Klin Wochenschr. 2018;130(9–10):307–313. doi:10.1007/s00508-018-1328-x
   PubMed Web of Science ®Google Scholar
• Moriya M, Nakatsuji Y, Okuno T, Hamasaki T, Sawada M, Sakoda S. Vitamin K2 ameliorates experimental autoimmune encephalomyelitis in Lewis rats. J Neuroimmunol. 2005;170(1–2):11–20. doi:10.1016/j.jneuroim.2005.08.001
   PubMed Web of Science ®Google Scholar
• Li J, Wang H, Rosenberg PA. Vitamin K prevents oxidative cell death by inhibiting activation of 12-lipoxygenase in developing oligodendrocytes. J Neurosci Res. 2009;87(9):1997–2005. doi:10.1002/jnr.22029
   PubMed Web of Science ®Google Scholar
• Carrié I, Portoukalian J, Vicaretti R, Rochford J, Potvin S, Ferland G. Menaquinone-4 concentration is correlated with sphingolipid concentrations in rat brain. J Nutr. 2004;134(1):167–172. doi:10.1093/jn/134.1.167
   PubMed Web of Science ®Google Scholar
• Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423:6937):356–61. doi:10.1038/nature01661
   Web of Science ®Google Scholar
• Smolen JS, Aletaha D, Barton A, et al. Rheumatoid arthritis. Nat Rev Dis Primers. 2018;4:18002. doi:10.1038/nrdp.2018.2
   PubMed Web of Science ®Google Scholar
• Bowman SJ. Hematological manifestations of rheumatoid arthritis. Scand J Rheumatol. 2002;31(5):251–259. doi:10.1080/030097402760375124
   PubMed Web of Science ®Google Scholar
• Pereira L, Monteiro R. Tailoring gut microbiota with a combination of Vitamin K and probiotics as a possible adjuvant in the treatment of rheumatic arthritis: a systematic review. Clin Nutr ESPEN. 2022;51:37–49. doi:10.1016/j.clnesp.2022.08.002
   PubMed Web of Science ®Google Scholar
• Huang YJ, Han L, Li J, Chen C. Acquired coagulation dysfunction resulting from vitamin K-dependent coagulation factor deficiency associated with rheumatoid arthritis: a case report. World J Clin Cases. 2022;10(1):236–241. doi:10.12998/wjcc.v10.i1.236
   PubMed Web of Science ®Google Scholar
• Xu W, Chen S, Wang X, et al. Suppressive effect of vitamin K2 against mitogen-activated peripheral blood mononuclear cells of rheumatoid arthritis patients. Int J Clin Pharmacol Ther. 2021;59(1):55–62. doi:10.5414/CP203827
   PubMed Web of Science ®Google Scholar
• Shiraki M, Shiraki Y, Aoki C, Miura M. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res. 2000;15(3):515–521. doi:10.1359/jbmr.2000.15.3.515
   PubMed Web of Science ®Google Scholar
• Iwamoto J, Takeda T, Ichimura S. Effect of menatetrenone on bone mineral density and incidence of vertebral fractures in postmenopausal women with osteoporosis: a comparison with the effect of etidronate. J Orthop Sci. 2001;6(6):487–492. doi:10.1007/s007760100002
   PubMedGoogle Scholar
• Purwosunu Y, Rachman IA, Reksoprodjo S, Sekizawa A. Vitamin K2 treatment for postmenopausal osteoporosis in Indonesia. J Obstetrics Gynaecol Res. 2006;32(2):230–234. doi:10.1111/j.1447-0756.2006.00386.x
   PubMed Web of Science ®Google Scholar
• Bolton-Smith C, McMurdo MET, Paterson CR, et al. Two-year randomized controlled trial of vitamin K1 (Phylloquinone) and Vitamin D3 plus calcium on the bone health of older women. J Bone Miner Res. 2007;22(4):509–519. doi:10.1359/jbmr.070116
   PubMed Web of Science ®Google Scholar
• Knapen MH, Schurgers LJ, Vermeer C. Vitamin K2 supplementation improves Hip bone geometry and bone strength indices in postmenopausal women. Osteoporos Int. 2007;18(7):963–972. doi:10.1007/s00198-007-0337-9
   PubMed Web of Science ®Google Scholar
• Cheung AM, Tile L, Lee Y, et al. Vitamin K supplementation in postmenopausal women with osteopenia (ECKO Trial): a randomized controlled trial. PLoS Med. 2008;5(1):- 12. doi:10.1371/journal.pmed.0050196
   Google Scholar
• Hirao M, Hashimoto J, Ando W, Ono T, Yoshikawa H. Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K2 in postmenopausal women. J Bone Miner Metab. 2008;26(3):260–264. doi:10.1007/s00774-007-0823-3
   PubMed Web of Science ®Google Scholar
• Tsugawa N, Shiraki M, Suhara Y, et al. Low plasma phylloquinone concentration is associated with high incidence of vertebral fracture in Japanese women. J Bone Miner Metab. 2008;26(1):79–85. doi:10.1007/s00774-007-0790-8
   PubMed Web of Science ®Google Scholar
• Je SH, Joo NS, Choi BH, et al. Vitamin K supplement along with vitamin D and calcium reduced serum concentration of undercarboxylated osteocalcin while increasing bone mineral density in Korean postmenopausal women over sixty-years-old. J Korean Med Sci. 2011;26(8):1093–1098. doi:10.3346/jkms.2011.26.8.1093
   PubMed Web of Science ®Google Scholar
• Knapen MH, Drummen NE, Smit E, Vermeer C, Theuwissen E. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos Int. 2013;24(9):2499–2507. doi:10.1007/s00198-013-2325-6
   PubMed Web of Science ®Google Scholar
• Jiang Y, Zhang ZL, Zhang ZL, et al. Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial. Clin Interv Aging. 2014;9:121–127. doi:10.2147/CIA.S54107
   PubMed Web of Science ®Google Scholar
• Rønn SH, Harsløf T, Pedersen SB, Langdahl BL. Vitamin K2 (menaquinone-7) prevents age-related deterioration of trabecular bone microarchitecture at the tibia in postmenopausal women. Europ J Endocrinol. 2016;175(6):541–549. doi:10.1530/EJE-16-0498
   PubMed Web of Science ®Google Scholar
• Shea MK, O’Donnell CJ, Hoffmann U, et al. Vitamin K supplementation and progression of coronary artery calcium in older men and women23. Am J Clin Nutr. 2009;89(6):1799–1807. doi:10.3945/ajcn.2008.27338
   PubMed Web of Science ®Google Scholar
• Cheung CL, Sahni S, Cheung BM, Sing CW, Wong IC. Vitamin K intake and mortality in people with chronic kidney disease from NHANES III. Clin Nutr. 2015;34(2):235–240. doi:10.1016/j.clnu.2014.03.011
   PubMed Web of Science ®Google Scholar
• Kurnatowska I, Grzelak P, Masajtis-Zagajewska A, et al. Effect of vitamin K2 on progression of atherosclerosis and vascular calcification in nondialyzed patients with chronic kidney disease stages 3–5. Pol Arch Med Wewn. 2015;125(9):631–640. doi:10.20452/pamw.3041
   PubMed Web of Science ®Google Scholar
• Brandenburg VM, Reinartz S, Kaesler N, et al. Slower progress of aortic valve calcification with vitamin K supplementation. Circulation. 2017;135(21):2081–2083. doi:10.1161/CIRCULATIONAHA.116.027011
   PubMed Web of Science ®Google Scholar
• Shea MK, Barger K, Booth SL, et al. Vitamin K status, cardiovascular disease, and all-cause mortality: a participant-level meta-analysis of 3 US cohorts. Am J Clin Nutr. 2020;111(6):1170–1177. doi:10.1093/ajcn/nqaa082
   PubMed Web of Science ®Google Scholar
• Shea MK, Dawson-Hughes B, Gundberg CM, Booth SL. Reducing undercarboxylated osteocalcin with vitamin K supplementation does not promote lean tissue loss or fat gain over 3 years in older women and men: a randomized controlled trial. J Bone Miner Res. 2017;32(2):243–249. doi:10.1002/jbmr.2989
   PubMed Web of Science ®Google Scholar
• Knapen MHJ, Jardon KM, Vermeer C. Vitamin K-induced effects on body fat and weight: results from a 3-year vitamin K2 intervention study. Eur J Clin Nutr. 2018;72(1):136–141. doi:10.1038/ejcn.2017.146
   PubMed Web of Science ®Google Scholar
• Aguayo-Ruiz JI, García-Cobián TA, Pascoe-González S, et al. Effect of supplementation with vitamins D3 and K2 on undercarboxylated osteocalcin and insulin serum levels in patients with type 2 diabetes mellitus: a randomized, double-blind, clinical trial. Diabetol Metab Syndr. 2020;12(1):73. doi:10.1186/s13098-020-00580-w
   PubMed Web of Science ®Google Scholar
• Rahimi Sakak F, Moslehi N, Niroomand M, Mirmiran P. Glycemic control improvement in individuals with type 2 diabetes with vitamin K(2) supplementation: a randomized controlled trial. Eur J Nutr. 2021;60(5):2495–2506. doi:10.1007/s00394-020-02419-6
   PubMed Web of Science ®Google Scholar